LUCHIN, Andrea
 Distribuzione geografica
Continente #
NA - Nord America 1.138
EU - Europa 205
AS - Asia 172
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 1.517
Nazione #
US - Stati Uniti d'America 1.136
CN - Cina 113
UA - Ucraina 58
DE - Germania 42
SG - Singapore 34
GB - Regno Unito 33
SE - Svezia 22
TR - Turchia 22
FI - Finlandia 15
IT - Italia 13
BE - Belgio 11
FR - Francia 4
RU - Federazione Russa 4
CA - Canada 2
AU - Australia 1
CZ - Repubblica Ceca 1
EU - Europa 1
IE - Irlanda 1
IN - India 1
IR - Iran 1
KZ - Kazakistan 1
RO - Romania 1
Totale 1.517
Città #
Ashburn 288
Woodbridge 165
Fairfield 97
Chandler 80
Ann Arbor 73
Jacksonville 72
Houston 65
Seattle 34
Cambridge 31
Wilmington 30
Beijing 29
Singapore 27
Addison 26
Nanjing 23
Izmir 19
Princeton 15
Boardman 12
Shanghai 12
Brussels 11
Milan 11
Dearborn 9
Changsha 7
Hebei 6
San Diego 6
Jinan 5
Kunming 5
Los Angeles 5
Guangzhou 4
Nanchang 4
San Mateo 4
Shenyang 4
Washington 4
Leawood 3
Norwalk 3
Santa Clara 3
Taizhou 3
Des Moines 2
Jiaxing 2
New York 2
Ottawa 2
Tappahannock 2
Tianjin 2
Acton 1
Almaty 1
Ardabil 1
Augusta 1
Bremen 1
Brno 1
Dublin 1
Falls Church 1
Ferrara 1
Formia 1
Hangzhou 1
Helsinki 1
Lappeenranta 1
London 1
Monmouth Junction 1
Mountain View 1
Mumbai 1
Prescot 1
Redwood City 1
Yellow Springs 1
Totale 1.227
Nome #
SRC homology-2-containing protein tyrosine phosphatase-1 restrains cell proliferation in human medullary thyroid carcinoma 337
Cyclooxygenase-2 inhibitors reverse chemoresistance phenotype in medullary thyroid carcinoma by a permeability glycoprotein-mediated mechanism 145
Selective activation of somatostatin receptor subtypes differentially modulates secretion and viability in human medullary thyroid carcinoma primary cultures: potential clinical perspectives. 141
Cyclooxygenase-2 inhibitors prevent the development of chemoresistance phenotype in a breast cancer cell line by inhibiting glycoprotein p-170 expression. 138
Proteasomes and RARS modulate AIMP1/EMAP II secretion in human cancer cell lines. 120
miR-15a and miR-16-1 down-regulation in pituitary adenomas 110
Role of complex Cdk4/Cyclin D1 in somatostatin subtype 2 receptor-mediated inhibition of cell proliferation of a medullary thyroid carcinoma cell line in vitro 89
Dopamine receptor 2 activation reduces cells viability in non-functioning pituitary adenomas by inhibiting vascular endothelial growth factor secretion 85
SHP-1 restrains cell proliferation in human medullary thyroid carcinoma 85
Chemoresistance of Medullary thryroid carcinoma cells is reversed by COX-2 inhibitors in vitro through a PGE2-dependent mechanism 71
Selective Cyclo-oxygenase 2 inhibitors revert chemoresistance In Medullary thyroid carcinoma by a mechanism mediated by P-gp and PGH2 70
Role of complex cyclin D1/Cdk4 in somatostatin subtype 2 receptor-mediated inhibition of cell proliferation of a medullary thyroid carcinoma cell line in vitro 69
Effects of pasireotide on bronchial carcinoids in primary culture 62
Totale 1.522
Categoria #
all - tutte 5.737
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.737


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020183 0 0 0 0 24 31 18 32 24 29 21 4
2020/2021167 21 16 3 18 10 15 6 19 4 19 27 9
2021/2022184 8 21 18 5 11 5 10 6 5 11 21 63
2022/2023167 15 15 13 20 25 28 12 11 20 1 4 3
2023/2024329 6 17 3 4 7 9 3 256 3 0 0 21
2024/202542 6 8 22 6 0 0 0 0 0 0 0 0
Totale 1.522